Harold J. Burstein
- Cancer Research top 0.05%
- Breast Cancer Treatment Studies 102
- Cancer Genomics and Diagnostics 17
- Oncology top 0.05%
- HER2/EGFR in Cancer Research 84
- Cancer Treatment and Pharmacology 81
- Peptidase Inhibition and Analysis 16
- Pathology and Forensic Medicine top 0.2%
- Breast Lesions and Carcinomas 16
- Pulmonary and Respiratory Medicine top 0.2%
- Advanced Breast Cancer Therapies 51
-
- Estrogen and related hormone effects 31
- Co-authors
- Eric P. WinerJane C. WeeksClifford A. HudisJennifer J. GriggsHope S. RugoAntonio C. WolffRebecca GelmanAnn H. Partridge
- Journals
- Journal of Clinical Oncology (71 papers)Breast Cancer Research and Treatment (18 papers)Annals of Oncology (13 papers)
- Partner nations
- United StatesItalySpain
In The Last Decade
Harold J. Burstein
214 papers receiving 18.6k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Cancer Research 7.1k
- Oncology 11.9k
- Pathology and Forensic Medicine 2.6k
- Pulmonary and Respiratory Medicine 4.4k
- Radiology, Nuclear Medicine and Imaging 2.8k
Countries citing papers authored by Harold J. Burstein
This map shows the geographic impact of Harold J. Burstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold J. Burstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold J. Burstein more than expected).
Fields of papers citing papers by Harold J. Burstein
This network shows the impact of papers produced by Harold J. Burstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold J. Burstein. The network helps show where Harold J. Burstein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Harold J. Burstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 20 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 52 | |
| 8 | 2022 | 5 | |
| 9 | 2020 | 6 | |
| 10 | Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Updatebreakdown → | 2018 | 411 |
| 11 | 2016 | 15 | |
| 12 | 2016 | 60 | |
| 13 | 2013 | 15 | |
| 14 | 2012 | 11 | |
| 15 | 2008 | 446 | |
| 16 | Updates in anti-HER2 combination therapy. | 2008 | 2 |
| 17 | 2006 | 105 | |
| 18 | 2006 | 150 | |
| 19 | Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinomabreakdown → | 2003 | 554 |
| 20 | 2002 | 221 |
About Harold J. Burstein
Harold J. Burstein is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 220 papers that have together received 19.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (102 papers), HER2/EGFR in Cancer Research (84 papers), Cancer Treatment and Pharmacology (81 papers), Advanced Breast Cancer Therapies (51 papers), Estrogen and related hormone effects (31 papers), Cancer Genomics and Diagnostics (17 papers), Peptidase Inhibition and Analysis (16 papers) and Breast Lesions and Carcinomas (16 papers). The work is most often cited by research in Cancer Research (7.1k citations), Oncology (11.9k citations) and Pathology and Forensic Medicine (2.6k citations). Harold J. Burstein has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Eric P. Winer, Jane C. Weeks, Clifford A. Hudis, Jennifer J. Griggs, Hope S. Rugo, Antonio C. Wolff, Rebecca Gelman, Ann H. Partridge, Stephen B. Edge and Mark R. Somerfield. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Annals of Oncology, The Breast and Journal of the National Comprehensive Cancer Network.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.